Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.75B |
| 2 |
MSLC
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
|
+$2.07B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.75B |
| 4 |
Apple
AAPL
|
+$1.6B |
| 5 |
Tesla
TSLA
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Strategy Inc
MSTR
|
+$1.3B |
| 4 |
Shopify
SHOP
|
+$1.14B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.55% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.08% |
| 5 | Communication Services | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Key Tronic
KTCC
$44.7M
| $7.2M | ﹤0.01% |
1,727,619
-61,650
| -3% | -$334K |
|
3627
BlackRock TCP Capital
TCPC
$345M
| $7.2M | ﹤0.01% |
826,855
-61,699
| -7% | -$534K |
|
3628
Fulcrum Therapeutics
FULC
$297M
| $7.2M | ﹤0.01% |
1,531,732
+1,181,047
| +337% | +$4.36M |
|
3629
Nelnet
NNI
$4.7B
| $7.2M | ﹤0.01% |
67,383
-17,658
| -21% | -$1.95M |
|
3630
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$771M
| $7.19M | ﹤0.01% |
39,045
+2,471
| +7% | +$465K |
|
3631
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$239M
| $7.18M | ﹤0.01% |
179,330
-6,459
| -3% | -$288K |
|
3632
National Presto Industries
NPK
$989M
| $7.18M | ﹤0.01% |
72,914
+3,443
| +5% | +$277K |
|
|
BRSP
3633
BrightSpire Capital
BRSP
$648M
| $7.16M | ﹤0.01% |
1,269,608
-318,087
| -20% | -$1.88M |
|
|
PRA
3634
DELISTED
ProAssurance
PRA
| $7.16M | ﹤0.01% |
449,932
-211,226
| -32% | -$3.36M |
|
3635
Acco Brands
ACCO
$407M
| $7.16M | ﹤0.01% |
1,363,285
-165,003
| -11% | -$917K |
|
3636
Adaptive Biotechnologies
ADPT
$3.97B
| $7.16M | ﹤0.01% |
1,193,835
+145,703
| +14% | +$803K |
|
3637
Mission Produce
AVO
$1.17B
| $7.13M | ﹤0.01% |
496,239
+35,142
| +8% | +$454K |
|
3638
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$912M
| $7.12M | ﹤0.01% |
680,920
-121,386
| -15% | -$1.32M |
|
|
AIV
3639
Aimco
AIV
$383M
| $7.1M | ﹤0.01% |
781,149
-1,139,555
| -59% | -$9.84M |
|
3640
United Fire Group
UFCS
$1.4B
| $7.08M | ﹤0.01% |
248,714
-28,329
| -10% | -$714K |
|
3641
Cytek Biosciences
CTKB
$546M
| $7.07M | ﹤0.01% |
1,089,461
+22,403
| +2% | +$133K |
|
3642
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
| $7.06M | ﹤0.01% |
149,593
+9,727
| +7% | +$475K |
|
3643
Leslie's
LESL
$11M
| $7.04M | ﹤0.01% |
157,920
+47,898
| +44% | +$2.54M |
|
3644
Franklin FTSE India ETF
FLIN
$2.69B
| $7.04M | ﹤0.01% |
185,660
+74,285
| +67% | +$2.93M |
|
3645
Barings BDC
BBDC
$965M
| $7.03M | ﹤0.01% |
734,753
+129,364
| +21% | +$1.26M |
|
3646
Old Second Bancorp
OSBC
$1.29B
| $7.03M | ﹤0.01% |
395,436
+30,683
| +8% | +$533K |
|
3647
Hillman Solutions
HLMN
$1.79B
| $7.03M | ﹤0.01% |
721,710
-113,851
| -14% | -$1.22M |
|
3648
KraneShares California Carbon Allowance Strategy ETF
KCCA
$116M
| $7.02M | ﹤0.01% |
358,040
+91,995
| +35% | +$1.95M |
|
3649
Enanta Pharmaceuticals
ENTA
$400M
| $7.02M | ﹤0.01% |
1,221,595
+118,743
| +11% | +$1.14M |
|
|
BCAX
3650
Bicara Therapeutics
BCAX
$1.84B
| $7.02M | ﹤0.01% |
402,918
+400,918
| +20,046% | +$8.34M |
|
Similar funds
Morgan Stanley's Q4 2024 Portfolio in Review
As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2024 filing shows 346 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
- Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
- Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
- Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
- Morgan Stanley opened 346 new positions and closed 287 in Q4 2024.
- Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.